This inventor holds 3 USPTO granted patents. Top assignee: The Feinstein Institutes for Medical Research. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: The Innovations of Jian Hua Li
Introduction
Jian Hua Li is an accomplished inventor based in New York, NY (US). He has made significant contributions to the field of medical research, particularly in the area of hypertension treatment. His innovative work has led to the development of a unique therapeutic approach that utilizes choline acetyltransferase.
Latest Patents
Jian Hua Li holds a patent for "Choline acetyltransferase as a therapy for hypertension." This patent includes compositions and methods that comprise choline acetyltransferase (ChAT) and PEGylated ChAT for treating hypertension. His work in this area has the potential to provide new avenues for managing this prevalent health issue.
Career Highlights
Li is affiliated with The Feinstein Institutes for Medical Research, where he continues to explore innovative solutions in medical science. His research focuses on the therapeutic applications of choline acetyltransferase, showcasing his commitment to advancing healthcare.
Collaborations
Throughout his career, Jian Hua Li has collaborated with notable colleagues, including Kevin J. Tracey and Sangeeta S. Chavan. These partnerships have enriched his research and contributed to the development of effective therapies.
Conclusion
Jian Hua Li's contributions to the field of hypertension treatment through his innovative patent demonstrate his dedication to improving medical outcomes. His work at The Feinstein Institutes for Medical Research continues to inspire advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile